Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€80.00

€80.00

-0.170%
-0.14
-0.170%
€91.20
 
15:36 / Tradegate WKN: A14M2J / Symbol: MDT / Name: Medtronic / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Medtronic plc Stock

The price for the Medtronic plc stock decreased slightly today. Compared to yesterday there is a change of -€0.140 (-0.170%).
With 20 Buy predictions and not the single Sell prediction the community is currently very high on Medtronic plc.
As a result the target price of 91 € shows a slightly positive potential of 13.75% compared to the current price of 80.0 € for Medtronic plc.
For the coming years our community has positive and negative things to say abot the Medtronic plc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.

Pros and Cons of Medtronic plc in the next few years

Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Medtronic plc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Medtronic plc -0.170% -0.062% 1.021% 0.175% 4.010% -4.573% -8.401%
Henry Schein Inc. -0.640% -2.154% -5.056% -14.090% -15.558% -17.025% 12.962%
Teleflex Inc. -0.980% -1.942% -4.717% -53.670% -39.881% -50.971% -64.685%
Dexcom Inc. 0.110% -3.802% -12.017% -5.958% -24.940% -32.367% -33.826%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-19

Upon first glance at Medtronic's financials, the company appears to be a strong player in the Healthcare Equipment & Supplies sector. Over the years, Medtronic has demonstrated relatively stable financial performance, which is a desirable attribute for a healthcare company. However, more in-depth analysis is needed to better understand the pros and cons of its financial situation.

Revenue Growth: Medtronic's total revenue has experienced consistent growth over the last three years as seen in the yearly income statements. In 2020, the company recorded total revenue of $28.913 billion which increased to $30.117 billion in 2021, and further to $31.686 billion in 2022.

Increasing Gross Profit: Medtronic has seen a rise in its gross profit, from $19.489 billion in 2020 to $19.634 billion in 2021, and eventually $21.541 billion in 2022. This implies that the company is becoming more efficient in its manufacturing and supply chain activities, which is a good sign for potential investors.

Comments

Prediction Buy
Perf. (%) -0.34%
Target price 87.724
Change
Ends at 17.09.26

Medtronic (NYSE:MDT) had its price target raised by analysts at Daiwa Capital Markets from $101.00 to $104.00. They now have a "buy" rating on the stock.
Ratings data for MDT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.91%
Target price 98.785
Change
Ends at 26.08.26

Medtronic (NYSE:MDT) had its price target raised by analysts at Argus from $105.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for MDT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.99%
Target price 86.698
Change
Ends at 21.08.26

Medtronic (NYSE:MDT) had its price target raised by analysts at Citigroup Inc. from $99.00 to $101.00. They now have a "buy" rating on the stock.
Ratings data for MDT provided by MarketBeat
Show more

News

1 Reason Medtronic (MDT) Is One of the Best Healthcare Stocks You Can Buy Today: https://g.foolcdn.com/editorial/images/830208/24_09_14-wooden-blocks-spelling-out-bull-and-bear-_mf-dload-gettyimages-1316129074-1201x656-9cff472.jpg
1 Reason Medtronic (MDT) Is One of the Best Healthcare Stocks You Can Buy Today

Medtronic (NYSE: MDT) is out of favor today, noting it has a historically high dividend yield of around 3%. The company is working on improving its business performance, however, and stronger

1 Reason Every Investor Should Know About Medtronic (MDT): https://g.foolcdn.com/editorial/images/830242/healthcare-professional-inspecting-charts.jpg
1 Reason Every Investor Should Know About Medtronic (MDT)

The list of Dividend Kings -- the very few U.S.-traded stocks that have enacted dividend raises at least once annually for a minimum of 50 years in a row -- is extremely short. That's why it's quite

Billionaire Ken Griffin Piled Into These 2 Unstoppable Dividend Stocks During the Second Quarter: https://g.foolcdn.com/editorial/images/832777/couple-shopping-in-a-retail-store.jpg
Billionaire Ken Griffin Piled Into These 2 Unstoppable Dividend Stocks During the Second Quarter

Ken Griffin is the founder and CEO of Citadel, a hedge fund established in 1990, whose long-term performance has been excellent. Citadel's track record suggests that Griffin knows a thing or two